Tirzepatide 40 mg is a subcutaneous injectable medication formulated to support clinically supervised weight management and metabolic control in adults. Tirzepatide functions as a dual GLP-1 and GIP receptor agonist, helping regulate appetite, promote satiety, and improve metabolic balance when combined with a structured diet and lifestyle program.

This formulation is supplied as a pre-filled pen for subcutaneous administration, intended for once-weekly dosing under the supervision of a qualified healthcare professional. The medication must be stored refrigerated between 2°C and 8°C to maintain stability and therapeutic integrity.

Manufactured to strict pharmaceutical-grade standards, Tirzepatide 40 mg ensures consistent potency, safety, and quality. It is a prescription-only medication and should be used strictly as directed by a licensed healthcare provider.

Key Features

• 40 mg subcutaneous injection

• Dual agonist targeting GLP-1 and GIP receptors

• Designed for once-weekly administration

• Supports appetite regulation and metabolic balance

• Requires refrigeration (2°C–8°C)

• Manufactured to pharmaceutical-grade standards

• Prescription-only, for supervised clinical use